Fei Jiang
- Cancer Research top 2%
- MicroRNA in disease regulation 18
- Cancer-related molecular mechanisms research 15
- Biomaterials top 2%
- Electrospun Nanofibers in Biomedical Applications 8
- Urology top 2%
- Molecular Biology top 5%
- Circular RNAs in diseases 11
- RNA modifications and cancer 9
- Molecular Medicine top 5%
-
- Tissue Engineering and Regenerative Medicine 13
-
- Bone Tissue Engineering Materials 13
-
- Mesenchymal stem cell research 11
- Cited by
- Cancer ResearchBiomaterialsUrology
- Journals
- Advanced Materials (4 papers)Scientific Reports (4 papers)Journal of Medicinal Chemistry (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Fei Jiang
187 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 158
- Cancer Research 708
- Biomaterials 491
- Urology 180
- Molecular Biology 1.7k
- Molecular Medicine 105
Countries citing papers authored by Fei Jiang
This map shows the geographic impact of Fei Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Jiang more than expected).
Fields of papers citing papers by Fei Jiang
This network shows the impact of papers produced by Fei Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Jiang. The network helps show where Fei Jiang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fei Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 10 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 7 | |
| 13 | 2022 | 5 | |
| 14 | 2022 | 4 | |
| 15 | 2021 | 6 | |
| 16 | 2021 | 13 | |
| 17 | 2019 | 180 | |
| 18 | Effects of vapor-permeable reflective film mulching on citrus tree micro-environment, shoot growth and fruit development. | 2017 | 2 |
| 19 | 320-detector row CT angiography in diagnosis of cerebral arteriovenous malformation with hemorrhage | 2013 | 1 |
| 20 | 2011 | 40 |
About Fei Jiang
Fei Jiang is a scholar working on Cancer Research, Genetics and Biomaterials, having authored 201 papers that have together received 4.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (18 papers), Cancer-related molecular mechanisms research (15 papers), Tissue Engineering and Regenerative Medicine (13 papers), Bone Tissue Engineering Materials (13 papers), Mesenchymal stem cell research (11 papers), Circular RNAs in diseases (11 papers), RNA modifications and cancer (9 papers) and Electrospun Nanofibers in Biomedical Applications (8 papers). The work is most often cited by research in Cancer Research (708 citations), Biomaterials (491 citations) and Urology (180 citations). Fei Jiang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Wenjie Zhang, Xinquan Jiang, Sihan Lin, Guangzheng Yang, Zhong Li, Xiaobing Shen, Yuan Li, Shi Yin, Yuezhi Lu and Shilong Ning. Their work appears in journals such as Advanced Materials, Scientific Reports, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Journal of Molecular Histology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.